Detalhe da pesquisa
1.
A randomized, double-blind, placebo-controlled trial with mannan-conjugated birch pollen allergoids.
Allergy
; 79(4): 990-1000, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822222
2.
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy.
Allergy
; 77(10): 3096-3107, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35570712
3.
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
Am J Respir Crit Care Med
; 204(4): 462-472, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33705665
4.
A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells.
Vet Dermatol
; 29(5): 449-e152, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30183126
5.
Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.
J Allergy Clin Immunol
; 138(2): 558-567.e11, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27177779
6.
Combination of Allergic Asthma Symptom and Medication Scores in Allergen Immunotherapy Trials: A Proposal.
Int Arch Allergy Immunol
; 182(7): 571-573, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33498057
7.
Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines.
Glycoconj J
; 33(1): 93-101, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603537
8.
Reducing Recurrent Urinary Tract Infections in Women with MV140 Impacts Personal Burden of Disease: Secondary Analyses of a Randomized Placebo-controlled Efficacy Study.
Eur Urol Open Sci
; 63: 96-103, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585593
9.
MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults.
Vaccines (Basel)
; 12(2)2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400155
10.
Sublingual MV140 for Prevention of Recurrent Urinary Tract Infections.
NEJM Evid
; 1(4): EVIDoa2100018, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319200
11.
Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.
Cell Rep
; 38(1): 110184, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986349
12.
Mite allergoids coupled to nonoxidized mannan from Saccharomyces cerevisae efficiently target canine dendritic cells for novel allergy immunotherapy in veterinary medicine.
Vet Immunol Immunopathol
; 190: 65-72, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28778325
13.
Comparison of the allergenicity and Ole e 1 content of 6 varieties of Olea europaea pollen collected during 5 consecutive years.
Ann Allergy Asthma Immunol
; 98(5): 464-70, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17521031
14.
Mite immunotherapy.
Curr Allergy Asthma Rep
; 6(5): 413-9, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16899204
15.
Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
J Allergy Clin Immunol
; 118(5): 1026-32, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17088125
16.
Comparative study of tolerance between unmodified and high doses of chemically modified allergen vaccines of Dermatophagoides pteronyssinus.
Int Arch Allergy Immunol
; 137(3): 211-8, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15956789